Rising safety and quality demands fuel expansion of U.S. supplement testing
With the U.S. supplement market continuing to expand, manufacturers are under increasing pressure to substantiate claims.
Thorvardur de Shong
Express Scripts court case spotlights PBM power
Express Scripts’ court fight with Martella Pharmacies underscores increasing scrutiny of PBMs and concerns over rural pharmacy closures.
Two-thirds of drug production facilities in disaster zones, ACS finds
A new ACS study shows that climate disasters have impacted nearly two-thirds of U.S. drug manufacturing sites, highlighting increasing risks of medication shortages.
AAP guidance breaks with federal policy on COVID-19 vaccination for kids
The pediatric association’s move contrasts with the CDC’s current position, which leaves vaccination decisions for healthy children up to parents and doctors.
Target reports Q2 earnings as sales decline
The retailer reaffirmed its full-year outlook despite investor concerns that sent shares down nearly 9% in early trading.
Canada authorizes Ozempic for kidney and heart protection in diabetes
Health Canada approved Ozempic to slow kidney disease and reduce heart deaths in type 2 diabetes, a first-of-its-kind approval that could help millions.
CRN unveils WellComms 2025 agenda
The event will include sessions on brand protection, influencer partnerships, effective press outreach, and more.
Ulta and Target to end in-store beauty partnership in 2026
Launched in August 2021, the collaboration brought prestige beauty brands to select Target stores and Target.com.
Costco pharmacies to stop offering abortion pill
The decision has drawn praise from religious investors and criticism from abortion rights supporters, as the battle over the pill shifts to CVS and Walgreens.
Aurobindo Pharma to acquire Lannett for $250M
The transaction is subject to regulatory approvals, including clearance from the U.S. Federal Trade Commission, and is expected to close within 8 to 12 months.
Cool Sips x poppi debut limited-edition dirty sodas
The partnership marks Cool Sips’ first collaboration with a national brand since launching in 2024, underscoring its rapid growth in the competitive beverage market.
Resonate: Most consumers only feeling mild tariff impact — For now
“Americans aren't pulling back yet, but tariffs have the potential to cause consumer behaviors to shift overnight,” said Bryan Gernert, CEO of Resonate.
Swiss government to meet pharma firms over U.S. tariffs
Pharma is Switzerland’s largest export sector to the U.S., accounting for half of all Swiss shipments to the States.
Remote patient monitoring market to top $40B by 2032
Home healthcare settings are projected to account for nearly one-third of RPM device demand in 2025.
WCC Biomedical brings WINMAP microneedle innovation to NACDS TSE
WCC sees potential for WINMAP to improve health equity, especially in low-resource areas where injection-based therapies are difficult to administer.
Kenvue cuts 2025 outlook as analysts lower price targets
“Kenvue is clearly a ‘show me’ story” that must prove it can deliver steady improvement before the stock can regain momentum.”